Genmab's Phase 2 Data: Acasunlimab Combination Shows Promise In Metastatic NSCLC

(RTTNews) - Genmab A/S (GMAB) and BioNTech SE (BNTX) announced initial data from the ongoing Phase 2 trial of acasunlimab in combination with pemb...

Related Keywords

, More Such Health News ,